Showing results (31-40 of 165) with videos related to
Sort By:
Pageof 17
Leukemia & Lymphoma|November 3, 2025
Safety profiles in elderly patients with DLBCL on first-line Pola-R-CHP: a claims database study in JapanYo Saito, Tetsuro Oda, Shimpei Nakanishi, et al.International Journal of Hematology|March 13, 2016
Identification of a novel putative mitochondrial protein FAM210B associated with erythroid differentiationAiko Kondo, Tohru Fujiwara, Yoko Okitsu, et al.Blood Advances|August 19, 2020
A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapyDavid G Maloney, Michinori Ogura, Noriko Fukuhara, et al.Cancer Science|January 21, 2026
Tafasitamab as Monotherapy or in Combination in Japanese Patients With B-Cell Non-Hodgkin Lymphoma: Results From the Phase 1b J-MIND StudyKoji Izutsu, Noriko Fukuhara, Junichiro Yuda, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|April 16, 2018
Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature reviewEikan Mishima, Takehiro Suzuki, Yoichi Takeuchi, et al.Genes, Chromosomes & Cancer|May 12, 2007
Chromosomal imbalances are associated with outcome of Helicobacter pylori eradication in t(11;18)(q21;q21) negative gastric mucosa-associated lymphoid tissue lymphomasNoriko Fukuhara, Tsuneya Nakamura, Masao Nakagawa, et al.Stem Cells (Dayton, Ohio)|September 20, 2016
An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple MyelomaMasahiko Kanehira, Tohru Fujiwara, Shinji Nakajima, et al.Journal of Clinical and Experimental Hematopathology : JCEH|June 22, 2022
Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantationMasahiro Miyazaki, Satoshi Ichikawa, Yasushi Onishi, et al.Leukemia & Lymphoma|May 18, 2016
Non-biased and complete case registration of lymphoid leukemia and lymphoma for five years: a first representative index of Japan from an epidemiologically stable Miyagi PrefectureHiroki Katsushima, Noriko Fukuhara, Satoshi Ichikawa, et al.Human Vaccines & Immunotherapeutics|January 10, 2023
Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccineJun Nomura, Masafumi Seki, Syori Abe, et al.Pageof 17